JP2009232853A5 - - Google Patents

Download PDF

Info

Publication number
JP2009232853A5
JP2009232853A5 JP2009136863A JP2009136863A JP2009232853A5 JP 2009232853 A5 JP2009232853 A5 JP 2009232853A5 JP 2009136863 A JP2009136863 A JP 2009136863A JP 2009136863 A JP2009136863 A JP 2009136863A JP 2009232853 A5 JP2009232853 A5 JP 2009232853A5
Authority
JP
Japan
Prior art keywords
hsc
progeny
hyaluronic acid
antagonist
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009136863A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009232853A (ja
Filing date
Publication date
Priority claimed from AUPR8565A external-priority patent/AUPR856501A0/en
Application filed filed Critical
Publication of JP2009232853A publication Critical patent/JP2009232853A/ja
Publication of JP2009232853A5 publication Critical patent/JP2009232853A5/ja
Pending legal-status Critical Current

Links

JP2009136863A 2001-10-30 2009-06-08 造血幹細胞およびその子孫の検出およびその使用 Pending JP2009232853A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR8565A AUPR856501A0 (en) 2001-10-30 2001-10-30 Detection of haematopoietic stem cells and progeny and uses thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2003540336A Division JP4354275B2 (ja) 2001-10-30 2002-10-24 造血幹細胞およびその子孫の検出およびその使用

Publications (2)

Publication Number Publication Date
JP2009232853A JP2009232853A (ja) 2009-10-15
JP2009232853A5 true JP2009232853A5 (cg-RX-API-DMAC7.html) 2009-11-26

Family

ID=3832387

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003540336A Expired - Fee Related JP4354275B2 (ja) 2001-10-30 2002-10-24 造血幹細胞およびその子孫の検出およびその使用
JP2009136863A Pending JP2009232853A (ja) 2001-10-30 2009-06-08 造血幹細胞およびその子孫の検出およびその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2003540336A Expired - Fee Related JP4354275B2 (ja) 2001-10-30 2002-10-24 造血幹細胞およびその子孫の検出およびその使用

Country Status (7)

Country Link
US (3) US20050003460A1 (cg-RX-API-DMAC7.html)
EP (1) EP1451303A4 (cg-RX-API-DMAC7.html)
JP (2) JP4354275B2 (cg-RX-API-DMAC7.html)
AU (2) AUPR856501A0 (cg-RX-API-DMAC7.html)
CA (1) CA2464956A1 (cg-RX-API-DMAC7.html)
IL (2) IL161690A0 (cg-RX-API-DMAC7.html)
WO (1) WO2003038071A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030228635A1 (en) * 2002-02-15 2003-12-11 Renovar, Inc. Cell proliferation assays and methods
US20100145032A1 (en) * 2007-01-18 2010-06-10 Suomen Punainen Risti, Veripalelu Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof
US9725689B2 (en) 2010-10-08 2017-08-08 Terumo Bct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
JP6057574B2 (ja) 2012-07-11 2017-01-11 キヤノン株式会社 造血幹細胞識別用プローブ
EP3068867B1 (en) 2013-11-16 2018-04-18 Terumo BCT, Inc. Expanding cells in a bioreactor
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
EP3198006B1 (en) 2014-09-26 2021-03-24 Terumo BCT, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US20170318781A1 (en) * 2016-05-03 2017-11-09 Cattle Time, Llc Combined visual and rf identification (rfid) tag
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
JP7393945B2 (ja) 2017-03-31 2023-12-07 テルモ ビーシーティー、インコーポレーテッド 細胞増殖
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP4314244B1 (en) 2021-03-23 2025-07-23 Terumo BCT, Inc. Cell capture and expansion
US12152699B2 (en) 2022-02-28 2024-11-26 Terumo Bct, Inc. Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875753B1 (en) * 1996-03-14 2005-04-05 The Governors Of The University Of Alberta Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
CA2324624A1 (en) * 1998-03-13 1999-09-16 Shawn J. Green Metastatin and hyaluronate binding proteins and methods of use
WO2000017326A1 (en) 1998-09-21 2000-03-30 Musc Foundation For Research Development Non-hematopoietic cells, including cardiomyocytes and skeletal muscle cells, derived from hematopoietic stem cells and methods of making and using them
FR2789587B1 (fr) * 1999-02-11 2003-01-24 Inst Nat Sante Rech Med Moyens pour la regulation de la differenciation hematopoietique
US20030032621A1 (en) * 2000-02-11 2003-02-13 Florence Smadja-Joffe Means for regulating hematopoietic differentiation
WO2002044345A1 (en) * 2000-12-01 2002-06-06 The General Hospital Corporation Methods and products for manipulating hematopoietic stem cells

Similar Documents

Publication Publication Date Title
WO2017100467A3 (en) Compositions and methods for internalizing enzymes
MX2010005343A (es) Compuestos indola 3, 5-sustituidos que tienen actividad inhibidora de la re-absorcion y el reciclo de nos y norepinefrina.
MX2009011949A (es) Inhibidores de proteina activadora de 5-lipoxigenasa (flap).
WO2007101864A3 (en) Compounds that modulate ppar activity, their preparation and use
WO2014066486A3 (en) Biomarker for use in treating anemia
JP2007523049A5 (cg-RX-API-DMAC7.html)
HK1199725A1 (en) Heterocyclic compounds and uses thereof
HK1198443A1 (en) Heterocyclic compounds and uses thereof
WO2009129335A3 (en) Selective inhibitors of histone deacetylase
WO2007141278A3 (en) Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof
NO20092444L (no) Heteroarylamidderivater
UA111464C2 (uk) Композиція, що містить моногліцериди органічних кислот c1-c7 та гліцерин, та її застосування як протибактеріального та протипліснявого засобу
BR112013023774A2 (pt) inibidores de glicosilceramida sintase
MX2007016462A (es) Composiciones topicas para tratar la piel.
RU2009118942A (ru) Способ стимуляции регенерации тканей
JP2008536487A5 (cg-RX-API-DMAC7.html)
HK1203356A1 (en) Pharmaceutical combinations comprising a thionucleotide analog
IN2015DN00934A (cg-RX-API-DMAC7.html)
TW202617995A (zh) 反義誘導之酸性α-葡萄苷酶中的外顯子2包含
EP2527441A3 (en) Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis
CL2008003201A1 (es) Composicion farmaceutica que comprende 0,5 a 50 mg de gaboxadol o una sal farmaceuticamente aceptable de este, y uno o mas inhibidores de pat1 y/o uno o mas inhibidores de oat, en donde dicha composicion brinda un perfil plasmatico in vivo con un tmax superior a 20 minutos, util en tratamientos de trastornos del sueno.
GEP201706741B (en) Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
EP4650364A3 (en) Materials and methods for treatment of pain related disorders
BR112014010729A2 (pt) métodos para tratamento de ataques de gota
WO2011131707A8 (en) ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES